BIOR
Closed
Biora Therapeutics Inc
0.22
0.00 (0.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.22
Day's Range: 0.22 - 0.22
Send
sign up or login to leave a comment!
When Written:
2.77
Biora Therapeutics Inc. is a biotechnology company that specializes in the development of novel therapies for the treatment of oral and dental diseases. The company was founded in 2000 and is headquartered in Malvern, Pennsylvania, USA.
Biora's primary focus is on the development of products that promote tissue regeneration and wound healing in the oral cavity. The company's flagship product is Emdogain, a protein-based therapeutic agent that stimulates the regeneration of periodontal tissue and is used in the treatment of periodontitis.
In addition to Emdogain, Biora also develops other products for the treatment of oral and dental diseases, including PeriAcryl, a surgical adhesive used to seal oral incisions and lacerations, and OraWax, a dental wax used to protect oral tissue during orthodontic treatment.
Biora has partnerships with several leading dental companies, including Dentsply Sirona, Henry Schein, and Straumann. The company has also received funding from various venture capital firms, including Versant Ventures, New Enterprise Associates, and Domain Associates.
Biora's mission is to improve the oral health and quality of life of patients by developing innovative therapies that promote tissue regeneration and wound healing in the oral cavity.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Biora's primary focus is on the development of products that promote tissue regeneration and wound healing in the oral cavity. The company's flagship product is Emdogain, a protein-based therapeutic agent that stimulates the regeneration of periodontal tissue and is used in the treatment of periodontitis.
In addition to Emdogain, Biora also develops other products for the treatment of oral and dental diseases, including PeriAcryl, a surgical adhesive used to seal oral incisions and lacerations, and OraWax, a dental wax used to protect oral tissue during orthodontic treatment.
Biora has partnerships with several leading dental companies, including Dentsply Sirona, Henry Schein, and Straumann. The company has also received funding from various venture capital firms, including Versant Ventures, New Enterprise Associates, and Domain Associates.
Biora's mission is to improve the oral health and quality of life of patients by developing innovative therapies that promote tissue regeneration and wound healing in the oral cavity.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!